PHASE-II STUDY OF TENIPOSIDE IN ADENOCARCINOMA OF THE LUNG

被引：3

作者：

SORENSEN, JB ^{[1
]}

BACH, F ^{[1
]}

DOMBERNOWSKY, P ^{[1
]}

HANSEN, HH ^{[1
]}

机构：

[1] UNIV COPENHAGEN,HERLEV HOSP,DK-2730 HERLEV,DENMARK

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1991年 / 27卷 / 06期

关键词：

D O I：

10.1007/BF00685166

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A total of 26 evaluable patients with previously untreated, non-resectable adenocarcinoma of the lung were given 80 mg/m2 i.v. teniposide daily for 5 days every 3 weeks. Three partial responses (11%) were obtained that lasted for 12, 11 and 32 weeks, respectively. Leucopenia was the dose-limiting side effect, with WBC counts of < 2 x 10(9)/l being observed in 42% of patients, resulting in one septic death. At the dose and schedule used in the present study, teniposide showed only limited activity in adenocarcinoma of the lung.

引用

页码：487 / 489

页数：3

共 50 条

[41] PHASE-II STUDY OF A 5-FLUOROURACIL, TENIPOSIDE AND MITOMYCIN-C COMBINATION CHEMOTHERAPY IN ADVANCED COLORECTAL CARCINOMAS
BECOUARN, Y
CALABET, J
BRUNET, R
TUMORI JOURNAL, 1988, 74 (01): : 75 - 77
[42] A PHASE-II STUDY OF NOLVADEX TAMOXIFEN CITRATE IN THE TREATMENT OF ADVANCED PROSTATIC ADENOCARCINOMA
SPREMULLI, E
DESIMONE, P
DURANT, J
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (02): : 149 - 153
[43] LH-RH ANALOG TREATMENT IN ADENOCARCINOMA OF THE PANCREAS - A PHASE-II STUDY
ALLEGRETTI, A
LIONETTO, R
SACCOMANNO, S
PAGANUZZI, M
ONETTO, M
MARTINOLI, C
ROLLANDI, G
MARUGO, M
FAZZUOLI, L
PUGLIESE, V
AZIONI, R
ARCURI, V
PERCIVALE, PL
BORGONOVO, G
BARTOLI, FG
ONCOLOGY, 1993, 50 (02) : 77 - 80
[44] ESORUBICIN IN PATIENTS WITH INOPERABLE ADENOCARCINOMA OF PANCREAS, PHASE-II
VAUGHN, CB
SALMON, S
JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (07): : 550 - 550
[45] PHASE-II TRIAL OF ESORUBICIN IN ADVANCED PANCREATIC ADENOCARCINOMA
BLAYNEY, DW
GOLDBERG, DA
LEONG, LA
CARR, BI
DOROSHOW, JH
CANCER TREATMENT REPORTS, 1986, 70 (05): : 683 - 684
[46] PHASE-II STUDY OF CYCLOPHOSPHAMIDE AND CYTARABINE IN THE TREATMENT OF METASTATIC ADENOCARCINOMA OF THE COLON AND RECTUM
DENEFRIO, JM
KAPLAN, RS
EISENBERGER, MA
LESSNER, HE
CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 163 - 164
[47] PHASE-II EVALUATION OF METOPRINE IN ADVANCED PANCREATIC ADENOCARCINOMA
STERNBERG, CN
MAGILL, GB
SORDILLO, PP
CHENG, EW
KEMENY, N
CANCER TREATMENT REPORTS, 1984, 68 (7-8): : 1053 - 1054
[48] PHASE-II STUDY OF 4'-DEOXYDOXORUBICIN (ESORUBICIN) IN ADVANCED OR METASTATIC ADENOCARCINOMA OF THE STOMACH
SOMLO, G
DOROSHOW, J
AKMAN, S
LEONG, L
MARGOLIN, K
MCNAMARA, M
MULTHAUF, P
BLAYNEY, D
MORGAN, R
RASCHKO, J
INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 83 - 85
[49] PHASE-II TRIAL OF MENOGAROL IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS
STERNBERG, C
MAGILL, G
CHENG, E
HOLLANDER, P
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 240 - 240
[50] PHASE-II EVALUATION OF ACLACINOMYCIN-A IN PATIENTS WITH ADENOCARCINOMA AND LARGE CELL-CARCINOMA OF THE LUNG
TAPAZOGLOU, E
SAMSON, MK
PAZDUR, R
HAAS, CD
BAKER, LH
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (04): : 298 - 301

← 1 2 3 4 5 →